Protagonist Therapeutics Inc
PTGX
Market Cap$2.94B
Close$
$1.33
97.5% downside
Current Fair Value
97.5% downsideOvervalued by 97.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.94 Billion |
|---|---|
| Enterprise Value | $2.83 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $4.47 |
| Beta | 2.64 |
| Outstanding Shares | 62,963,806 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 53.19 |
|---|---|
| PEG | -50.36 |
| Price to Sales | 17.94 |
| Price to Book Ratio | 5.38 |
| Enterprise Value to Revenue | 13.63 |
| Enterprise Value to EBIT | 104.31 |
| Enterprise Value to Net Income | 50 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data